levodopa has been researched along with dantrolene in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Accardo, PJ; Farrell, SE; Roizen, NJ; Rubenstein, JE; Vining, EP | 1 |
| Ogawa, N; Yamawaki, Y | 2 |
| Lazarus, A | 1 |
| Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK | 1 |
| Cape, G | 1 |
| Ishiguro, T; Nisijima, K; Noguti, M | 1 |
| Reingardiene, D | 1 |
| Castro, A; Dapena, MD; Linazasoro, G; Van Blercom, N | 1 |
| Ward, C | 1 |
| Bahi-Buisson, N; Doummar, D; Echenne, B; Payet, C; Roubertie, A; Roze, E | 1 |
| Ando, Y; Sakamoto, M; Shindo, Y; Shinoda, M; Tateda, T | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
5 review(s) available for levodopa and dantrolene
| Article | Year |
|---|---|
Cerebral palsy. A pediatric developmentalist's overview.
Topics: Cerebral Palsy; Dantrolene; Diazepam; Humans; Levodopa; Occupational Therapy; Phenothiazines; Physical Therapy Modalities; Psychotherapy; Speech Therapy | 1976 |
Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Topics: Aged; Antithrombins; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease | 1992 |
[Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Topics: Aged; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease | 1991 |
[Neuroleptic malignant syndrome].
Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis | 2002 |
[Treatment of childhood dystonia].
Topics: Algorithms; Anticonvulsants; Benzodiazepines; Botulinum Toxins, Type A; Child; Cholinergic Antagonists; Cooperative Behavior; Dantrolene; Deep Brain Stimulation; Dopamine Agents; Dystonic Disorders; Humans; Interdisciplinary Communication; Levodopa; Muscle Relaxants, Central; Patient Care Team; Prognosis | 2010 |
8 other study(ies) available for levodopa and dantrolene
| Article | Year |
|---|---|
Therapy of neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine | 1986 |
Management of neuroleptic malignant syndrome--a series of eight cases.
Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome | 1993 |
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combined Modality Therapy; Critical Care; Dantrolene; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizoid Personality Disorder; Sick Role; Social Environment; Substance Withdrawal Syndrome | 1994 |
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
Topics: Adult; Dantrolene; Dopamine Agents; Female; Humans; Injections, Intravenous; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia | 1997 |
Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Topics: Analgesics, Non-Narcotic; Anti-Infective Agents; Antiparkinson Agents; Combined Modality Therapy; Consciousness Disorders; Dantrolene; Deep Brain Stimulation; Diagnosis, Differential; Diagnostic Errors; Dystonic Disorders; Encephalitis; Female; Fluid Therapy; Foot; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Muscle Relaxants, Central; Parkinson Disease; Selegiline; Substance Withdrawal Syndrome; Tachycardia | 2004 |
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Agents; Drug Monitoring; Electrolytes; Fever; Humans; Leukocyte Count; Levodopa; Magnetic Resonance Imaging; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Nurse's Role; Nursing Assessment; Parkinson Disease; Physical Examination; Substance Withdrawal Syndrome; Time Factors; Urinalysis | 2005 |
[Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
Topics: Aged, 80 and over; Anesthesia; Aortic Aneurysm, Thoracic; Cardiac Surgical Procedures; Dantrolene; Extracorporeal Circulation; Female; Humans; Infusions, Intravenous; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Perioperative Care; Postoperative Complications | 2013 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |